Q1 2022 Seres Therapeutics Inc Earnings Call Transcript
Welcome to the Seres Therapeutics First Quarter 2022 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.
I would now like to turn the conference over to Dr. Carlo Tanzi, Head of Investor Relations. Please go ahead.
Thank you, Emily, and good morning. Our press release with the company's first quarter 2022 financial results and a business update became available at 7:00 a.m. Eastern Time this morning and can be found on the Investors and News section of the company's website.
I'd like to remind you that we will be making forward-looking statements, including the potential approval of SER-109 and its status as a first-in-class therapeutic, the timing of a BLA filing and potential product launch, the market for SER-109, our development opportunities and the ultimate safety and efficacy data for our products. Actual results may differ materially.
Additionally, these statements are subject to certain risks and uncertainties, which are
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |